May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
In vitro and in vivo Release Profile of a New Ciprofloxacin Hydrochloride Biodegradable Controlled Release Microspheres System Optimized for Sub–Tenon’s Capsule Delivery
A.A. Silva; B. Wanczinski; A.G. Oliveira; J.A. Cardillo; F. Paganelli; R.A. Costa; M. Skaf; A.A. Souza–Filho; R. Belfort, Jr; B.D. Kuppermann
Author Affiliations & Notes
  • A.A. Silva
    Famacos e Medicamentos, Faculdade deCiencias FarmacUNESP, Araraquara–SP, Brazil
  • B. Wanczinski
    Famacos e Medicamentos, Faculdade de Ciencias FarmacUNESP, Araraquara–SP, Brazil
  • A.G. Oliveira
    Famacos e Medicamentos, Faculdade de Ciencias FarmacUNESP, Araraquara–SP, Brazil
  • J.A. Cardillo
    Ophthalmology, Hospital de Olhos de Araraquara, Araraquara–SP, Brazil
  • F. Paganelli
    Ophthalmology, Hospital de Olhos de Araraquara, Araraquara–SP, Brazil
  • R.A. Costa
    Ophthalmology, Hospital de Olhos de Araraquara, Araraquara–SP, Brazil
  • M. Skaf
    Ophthalmology, Hospital de Olhos de Araraquara, Araraquara–SP, Brazil
  • A.A. Souza–Filho
    Department of Pharmacology,
    Federal University of Sao Paulo, UNIFESP–EPM, Sao Paulo, Brazil
  • R. Belfort, Jr
    Ophthalmology,
    Federal University of Sao Paulo, UNIFESP–EPM, Sao Paulo, Brazil
  • B.D. Kuppermann
    Department of Ophthalmolgy, University California Irvine, Irvine, CA
  • Footnotes
    Commercial Relationships  A.A. Silva, None; B. Wanczinski, None; A.G. Oliveira, None; J.A. Cardillo, None; F. Paganelli, None; R.A. Costa, None; M. Skaf, None; A.A. Souza–Filho, None; R. Belfort , Jr., None; B.D. Kuppermann, None.
  • Footnotes
    Support  fapesp,cnpq,capes and padc unesp
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 5395. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      In vitro and in vivo Release Profile of a New Ciprofloxacin Hydrochloride Biodegradable Controlled Release Microspheres System Optimized for Sub–Tenon’s Capsule Delivery
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      A.A. Silva, B. Wanczinski, A.G. Oliveira, J.A. Cardillo, F. Paganelli, R.A. Costa, M. Skaf, A.A. Souza–Filho, R. Belfort, Jr, B.D. Kuppermann; In vitro and in vivo Release Profile of a New Ciprofloxacin Hydrochloride Biodegradable Controlled Release Microspheres System Optimized for Sub–Tenon’s Capsule Delivery . Invest. Ophthalmol. Vis. Sci. 2005;46(13):5395.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Abstract: : Purpose: To study the in vitro and in vivo release profile of a ciprofloxacin (CP) biodegradable controlled release microspheres system developed for ocular sub–Tenon’s capsule application. Methods: CP and polylactic–co–glycolic acid (PLGA) were dissolved in acetone in order to obtain the relationship CP/PLGA 1:1 and 1:2. The drug loading was determined dissolving both, the PLGA and CP in glacial acetic acid. The CP loading efficiency and quantitative analysis were determined by high performance liquid chromatography and the morphology assessed by scanning electronic microscopy. In vitro, 1mg of CP microspheres was incubated in phosphate buffer and serial CP measurements performed. In vivo, 1mg/0.1mL CP loaded microspheres were injected in the sub–Tenon’s capsule space of 30 albino rabbits and the overtime released CP concentration determined in the aqueous and vitreous humors up to 10 days. Results: The PLGA microspheres showed roughly spherical shape and uniform particle size distribution around 2µm. The encapsulation efficiency was in the range of 90.5 + 4.5%. The in vitro release time from the CP/PLGA 1:1 microsphere was 24 hours and 15 minutes for the free CP form. In vivo, the free CP form remained in therapeutic levels for 12 hours in both, aqueous and vitreous humors. The CP/PLGA 1:1 microesphere system reached therapeutic levels within 12 hours following the sub–Tenon’s capsule injection and remained in this range up to 7 days. Conclusions: This micro sphere biodegradable system demonstrated in vitro and in vivo the potential to proportionate a more sustained and steady CP release profile than the CP free form after sub–Tenon’s capsule application. This is a rational approach for extra–ocular controlled drug delivery and may have broad applications in clinical ophthalmology

Keywords: antibiotics/antifungals/antiparasitics 
© 2005, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2025 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept